ECCO 2019 European Cancer Summit


Please click on the video thumbnail to view the related webcast.

Since we met last time

Prof Mehmet Ungan
WONCA Europe 
Simon Oberst
Organisation of European Cancer Institutes (OECI)  
Prof Françoise Meunier
Federation of European Academies of Medicine (FEAM) 
Kathy Oliver
International Brain Tumour Alliance (IBTA), ECCO Patient Advisory Committee
Prof Yolande Lievens
European SocieTy for Radiotherapy and Oncology (ESTRO) 

‘Putting a person on the moon’: How to deliver mission orientated cancer activity 


Dr Jan-Willem van de Loo
European Commission’s Directorate-General for Research and Innovation 

Prof Thierry Philip
President of the Organisation of European Cancer Institutes (OECI) 

Prof Gilles Vassal
European Society of Paediatric Oncology (SIOP Europe)
Prof Véronique Trillet-Lenoir, MEP
Liste Renaissance, France
Prof Mark Lawler
Queen’s University Belfast and the European Cancer Concord 
Panel Discussion

Resolution Session: Eliminating HPV related cancers 

Dr Maria Kyrgiou
Imperial College London
Dr Murat Gultekin
ESGO Prevention & Diagnostics Task Force and the European Network of Gynaecological Cancer Advocacy Groups (ENGAGe) 

Peter Baker
HPV Action UK

Prof Daniel Kelly
European Oncology Nursing Society (EONS) 
 Panel Discussion  

Spotlight session: Clinical Trials Across Borders 

Teodora Lalova
EORTC Research Fellow
Panel Discussion 

Artificial Intelligence: Breaking down borders in cancer care in ways not yet known?


Prof Regina Beets-Tan
ECCO Board Member and European Society of Radiology (ESR)

Prof Ivana Isgum
Image Sciences Institute at UMC Utrecht 
 Saila Rinne
 DG CONNECT, European Commission
Panel Discussion 

In conversation with…

Dr Vytenis Andriukaitis
EU Commissioner for Health and Food Safety 2014-2019 
Panel Discussion 

Accessing treatment across borders: don’t stop us now! 

Caroline Hager
Directorate-General for Health and Food Safety of the European Commission
Hélène le Borgne
 Directorate-General for Health and Food Safety of the European Commission
 Prof Béatrice Gulbis
 ERN EuroBloodNet
Dr Annalisa Trama
Lejla Kameric
 Childhood Cancer International
Prof Ruth Ladenstein
ERN PaedCan 
 Panel Discussion  

How does access to innovative cancer medicines fit in high quality cancer care and well-functioning health system as a whole?


Dr Kim Linton
The University of Manchester

Dr Detlev Parow 
 DAK-Gesundheit, Germany
 Usman Khan
 European Patients’ Forum
Dr Alexandre Lourenço
 Portuguese Association of Hospital Managers, Portugal 
 Maria Krini
The Cyprus Association of Cancer Patients and Friends (PASYKAF)
Panel Discussion 

Clinical cancer research across Europe: Do we need to change tracks? 

 Dr Denis Lacombe
 European Organisation for Research and Treatment of Cancer (EORTC)
 Dr Magda Chlebus
 European Federation of Pharmaceutical Industries and Associations (EFPIA)
Dr Ralf Herold
 Scientific Officer, the European Medicines Agency (EMA) 
Panel Discussion

In conversation with…


Dr Blase N. Polite
 American Society of Clinical Oncology (ASCO) 


Specialisation in cancer care: It's a cross border issue 

Dr Andreas Charalambous
European Oncology Nursing Society (EONS)
Prof Klaus Meier
European Society of Oncology Pharmacy (ESOP)
Prof Sergio Sandrucci
European Society of Surgical Oncology (ESSO) 
Panel Discussion 

Molecular tumour diagnostics in cancer care: should it be an essential requirement?

 Prof Peter Schirmacher
 European Society of Pathology (ESP)
 Jan Geissler
 CML Advocates Network and ECCO Patient Advisory Committee
 Prof Koen Norga
European Medicines Agency (EMA)
Prof Sir John Burn
European Hereditary Tumour Group (EHTG) 
 Prof Crispin Hiley
Radiation Oncology Consultant & Associate at the Francis Crick Institute, UK
 Prof Fatima Carneiro
University of Porto
 Panel Discussion